Emmanuel J. Favaloro

TL;DR: This work describes 13 individuals from five unrelated families in Australia with type 2B VWD, report their phenotypic abnormalities, and delineate their causative mutations, confirming that the mutation Arg543Trp is also particularly common among families with type 1B V WD in Australia.

TL;DR: A statistically significant influence of ABO-blood group on APTT test times, both in the presence and absence of Activated Protein C (APC), which was no longer evident when using assay ratios, and an age related increase in APTT ratios is observed.

TL;DR: It is identified that hs-cTn testing may provide valuable information for predicting future adverse outcomes and mortality, independently from baseline clinical risk assessment, and the future development of updated risk stratification models, with the inclusion of laboratory tests such as hs, may represent an enhanced approach forrisk stratification in patients with acute PE.

TL;DR: Testing of some acquired markers of thrombophilia, such as lupus anticoagulant, and genetic tests such as factor V Leiden and prothrombin G20210A mutation, are also available and some diversity is also apparent.